A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251.
about
Chronic alcohol abuse and HIV disease progression: studies with the non-human primate modelNonhuman primate models for HIV/AIDS vaccine developmentUsing nonhuman primates to model HIV transmissionHIV vaccine development: strategies for preclinical and clinical investigationTracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmissionIn captive rhesus macaques, cervicovaginal inflammation is common but not associated with the stable polymicrobial microbiomeVaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tractSHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant virusesSurvivors Remorse: antibody-mediated protection against HIV-1.Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primatesNew directions for HIV vaccine development from animal models.Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection eventsLow-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.Evaluation of cervical mucosa in transmission bottleneck during acute HIV-1 infection using a cervical tissue-based organ culture.Fcgbp - A Potential Viral Trap in RV144Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibodyLow Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users.The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.AIDS vaccines and preexposure prophylaxis: is synergy possible?Viral RNA levels and env variants in semen and tissues of mature male rhesus macaques infected with SIV by penile inoculation.Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaquesBarriers to mucosal transmission of immunodeficiency viruses.SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma.Significant genetic heterogeneity of the SIVmac251 viral swarm derived from different sources.Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.Innate immunity in acute HIV-1 infectionGeneration and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides.Macaque models of enhanced susceptibility to HIV.Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaMucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sitesCharacterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaquesEarly low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape.Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.
P2860
Q26852432-C7AA8117-E25F-4580-B614-63A4D4B0ABEAQ26861148-42C04918-5C28-4E6C-B783-E3A5B892C363Q26861425-C1935C85-AE84-46CF-A05A-5A755D42B897Q27025917-CC26E1D4-D89E-4045-A5FC-054A52DABD55Q27313356-4EE1F7EF-ECE8-422D-87EC-76288C453894Q27323257-3A5FF8EA-B24A-4B3E-B12E-84C9728E83EAQ27323310-30F0354E-BCAF-49D0-A76F-3E9D6624FDBFQ28742018-A73F44DD-A6E6-48F8-83BB-41C109936EEAQ30238730-3C84E07B-F2B7-4674-88C6-8CD3E3571747Q33355730-A42D5A0B-82DD-4266-82F7-E6178412822FQ33767191-3C13EA92-9102-46AF-BA12-7666C3BFCE1CQ33900353-05B2D758-D28A-418E-9D54-2C5BE13B1852Q34120840-410EFE2E-72B1-4924-9650-F69E7261628FQ34193198-3C94E82C-5511-4008-8C65-6C366DEF83A1Q34201287-8DC657D4-630D-4A27-9B1D-072187324C59Q34243486-552E8F1A-F024-4B07-B13A-23BFEA53CFBEQ34379806-88BE35D2-01E1-47E9-8CA8-FC06DC771AD6Q34433975-D51BED28-D159-49E2-86C0-6698286F8807Q34630446-A68A1D09-30AC-42C7-BE9A-30CD83388A5BQ34802271-D1E5A707-1E09-4C3B-A3BC-763620393875Q34982693-511CF249-A27E-435E-ADEB-0071EDACA064Q35003539-A85D2D40-0F89-47A8-B15A-A13407BBF7FFQ35022735-82DCAC99-BD9F-42AE-84F2-4AF7C9DF638DQ35076961-A2958924-902D-4CA6-BC52-DA5103E40D9AQ35138516-35EA6D07-E73D-4BBB-8975-BE3B22E89FA8Q35140968-37C14607-114D-4352-B0C4-1365B7AB12B0Q35581949-AEC02305-AC64-45FD-B877-C90AF0F214CAQ35581953-23F28CF3-21CF-4326-AFD1-811F800EF78AQ35658952-48468424-A4FA-41D7-AEC5-7B79BA216715Q35667426-330FEB40-08AA-4239-A2D7-ED550521A37AQ35696991-DF3D7FAF-9191-4B48-937A-36ABBC945654Q35748138-5C39BEE6-4294-4D17-88F1-815585D395B6Q35776556-4618F547-04CD-4E34-A6E5-5BAA791E5A3AQ35826525-9473FD2F-9652-4F1A-83F3-AF0D763C335DQ35868061-4A3CA6A2-4BB2-4154-A0A4-5BCA111CD5FBQ35914362-515FE4F8-EA02-4A6D-B4F0-CB96A78D1F24Q35915659-DCDBE234-299F-4125-9FB9-CD552E206EBDQ36000736-06EF1307-DDDC-4E25-8DAB-391F78C015FAQ36009232-29D4BF3D-813D-416E-8E3D-7ADC528C8CFCQ36154787-06DE6391-B451-4CD8-A921-7AC7AF8A1F55
P2860
A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A limited number of simian imm ...... lly inoculated with SIVmac251.
@ast
A limited number of simian imm ...... lly inoculated with SIVmac251.
@en
type
label
A limited number of simian imm ...... lly inoculated with SIVmac251.
@ast
A limited number of simian imm ...... lly inoculated with SIVmac251.
@en
prefLabel
A limited number of simian imm ...... lly inoculated with SIVmac251.
@ast
A limited number of simian imm ...... lly inoculated with SIVmac251.
@en
P2093
P2860
P50
P356
P1433
P1476
A limited number of simian imm ...... lly inoculated with SIVmac251.
@en
P2093
Christopher J Miller
Elizabeth Bailes
Joseph Dutra
Mars Stone
Zhong-Min Ma
P2860
P304
P356
10.1128/JVI.00481-10
P407
P577
2010-05-12T00:00:00Z